Open Source Drug Discovery

Tuesday, August 3, 2010

Bravo!! Congratulations to CSIR scientists and all the students involved in C2D phase First.


अद्भुत कार्य:-A Reality
Hundreds of scientists from across the country put in joint efforts at a three-day 'Connect 2 Decode' (C2D) conference to complete the final re-annotation of the 4,000- odd genes that determine how the TB bug lives and infects humans.
This is the first time that a comprehensive mapping of the Mtb genome has been compiled, verified and made publicly available. C2D's findings may contain critical data to unlock previously undiscovered details of tuberculosis (TB)
  • We need to have a balanced view between health as a right and health as a business. It is because there has been imbalance in this view that diseases like TB, with high mortality but low profitability, are neglected by the current system of pharmaceutical research,” said Dr. Samir K. Brahmachari, scientist and Director-General of the Council of Scientific and Industrial Research (CSIR).
  • C2D demonstrates the power of people to connect through the internet, particular young people, and accomplish complex research tasks. It is also a distinct move from a hierarchical based model of doing science towards one of equal collaboration.", project director Zakir Thomas said.

  • OSDD is a completely new formula across the world. Here we are making all our progress available to public. Anyone can take advantage and develop a drug based on our research. The aim here is not patents but drug discovery for a neglected disease," said Rajesh Gokhle, a senior scientist associated with the project.
Under the C2D project, researchers and students pooled their time and skills using online tools to provide insights into 4,000 genes of the deadly pathogen.
The MTB map has been hosted on a web portal (www.osdd.net) custom-developed by Infosys and uses an emerging format (Web 3.0) that allows users to get better search results while searching for data for research .



No comments:

Post a Comment